Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

AstraZeneca
Chinese Patent Office
Colorcon
McKinsey
Dow
Express Scripts
Mallinckrodt
QuintilesIMS
Merck

Generated: May 24, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 018885

« Back to Dashboard

NDA 018885 describes EMBOLEX, which is a drug marketed by Novartis and is included in one NDA. Additional details are available on the EMBOLEX profile page.

The generic ingredient in EMBOLEX is dihydroergotamine mesylate; heparin sodium; lidocaine hydrochloride. There are five drug master file entries for this compound. Additional details are available on the dihydroergotamine mesylate; heparin sodium; lidocaine hydrochloride profile page.
Summary for 018885
Tradename:EMBOLEX
Applicant:Novartis
Ingredient:dihydroergotamine mesylate; heparin sodium; lidocaine hydrochloride
Patents:0
Formulation / Manufacturing:see details

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:INJECTABLE;INJECTIONStrength0.5MG/0.5ML;2,500 UNITS/0.5ML;5.33MG/0.5ML
Approval Date:Nov 30, 1984TE:RLD:No

Profile for product number 002

Active Rx/OTC/Discontinued:DISCNDosage:INJECTABLE;INJECTIONStrength0.5MG/0.7ML;5,000 UNITS/0.7ML;7.46MG/0.7ML
Approval Date:Nov 30, 1984TE:RLD:No

Expired US Patents for NDA 018885

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Novartis EMBOLEX dihydroergotamine mesylate; heparin sodium; lidocaine hydrochloride INJECTABLE;INJECTION 018885-002 Nov 30, 1984 ➤ Sign Up ➤ Sign Up
Novartis EMBOLEX dihydroergotamine mesylate; heparin sodium; lidocaine hydrochloride INJECTABLE;INJECTION 018885-001 Nov 30, 1984 ➤ Sign Up ➤ Sign Up
Novartis EMBOLEX dihydroergotamine mesylate; heparin sodium; lidocaine hydrochloride INJECTABLE;INJECTION 018885-002 Nov 30, 1984 ➤ Sign Up ➤ Sign Up
Novartis EMBOLEX dihydroergotamine mesylate; heparin sodium; lidocaine hydrochloride INJECTABLE;INJECTION 018885-001 Nov 30, 1984 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Johnson and Johnson
QuintilesIMS
Colorcon
Moodys
Fuji
US Army
Federal Trade Commission
AstraZeneca
Fish and Richardson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.